VIRACTA THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6275 USD | -6.87% |
|
+7.63% | +10.09% |
| 12/06 | XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher | MT |
| 30/05 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -6.87% | +7.63% | +10.09% | -59.78% | - | 26.46M |  | | |
- Stock Market
- Equities
- VIRX Stock
- Charts Viracta Therapeutics, Inc.
- Relative Strength Chart
